Physical, Biological and Effective Half-Life
Once a radioactive tracer is inside the body, it doesn't just sit there decaying in isolation — the body itself is actively working to get rid of it, through ordinary metabolism and excretion, at exactly the same time as the tracer is undergoing radioactive decay. Two independent clocks are ticking at once, and working out how they combine is essential to understanding the dose a patient actually receives.
Two independent ways to lose activity
A dose of radioactive tracer introduced into the body is removed by two entirely separate processes happening simultaneously, and it's important to keep them conceptually distinct before combining them.
- Physical half-life, $T_P$ — the ordinary radioactive half-life of the isotope itself: the time taken for half of the radioactive nuclei present to decay. This is a fixed property of the isotope, entirely independent of whether it happens to be inside a body at all — the same $T_P$ would apply to a sample of the isotope sitting in a lead-lined box on a shelf.
- Biological half-life, $T_B$ — the time taken for the body's own natural processes (metabolism, excretion via the kidneys, liver, and so on) to eliminate half of an introduced substance from the body. This depends entirely on the chemistry of the substance and the body's handling of it, and is completely independent of whether that substance happens to be radioactive — a non-radioactive version of the same compound would be eliminated with exactly the same $T_B$.
Because both processes act on the same population of tracer atoms at the same time, the radioactive material actually present at the target site in the body decreases faster than either process would achieve on its own — decay removes some, while biological elimination removes more of what's left, continuously and simultaneously.
Combining them: effective half-life
The effective half-life, $T_E$, is the overall, combined half-life describing how quickly the amount of radioactive tracer present at the target site actually falls, taking both loss mechanisms into account together. It is given by the reciprocal-sum relationship:
This has exactly the same mathematical form as combining resistances in parallel, or combining rates that act concurrently and independently — each process contributes its own "rate" of removal ($1/T_P$ and $1/T_B$), and the combined rate ($1/T_E$) is simply their sum.
The reverse form of this calculation is just as commonly tested: given $T_E$ and one of $T_P$ or $T_B$, find the other. Rearranging the relationship for $T_B$ (finding the missing biological half-life given the physical and effective half-lives) gives:
For example, if a tracer is measured to have an effective half-life $T_E = 5.0$ hours and is known to have physical half-life $T_P = 6.0$ hours, then $\dfrac{1}{T_B} = \dfrac{1}{5.0} - \dfrac{1}{6.0} = 0.200 - 0.1667 = 0.0333\ \text{h}^{-1}$, giving $T_B \approx 30$ hours. The same rearrangement, swapping $T_P$ and $T_B$, finds a missing physical half-life given the effective and biological half-lives instead.
Because $\frac{1}{T_E}$ is the sum of two positive quantities, $\frac{1}{T_E}$ is always larger than either $\frac{1}{T_P}$ or $\frac{1}{T_B}$ alone — which means $T_E$ is always shorter than both $T_P$ and $T_B$ individually. This follows directly from the reciprocal-sum formula itself, without needing to calculate a specific example: combining two independent ways of losing material can never make the overall loss slower than either mechanism acting alone.
Why effective half-life drives patient dose
This isn't just a piece of algebra — it has real clinical weight. The radiation dose a patient receives from an internal tracer depends on how long radioactive material actually remains present and decaying inside the body, which is governed by $T_E$, not by $T_P$ alone.
Because $T_E$ is always shorter than $T_P$, using effective half-life rather than physical half-life alone to estimate dose reflects the fact that the body is actively helping to clear the tracer away, in addition to the tracer simply decaying on its own. Estimating dose from physical half-life alone would overstate how long the tracer remains active in the body, since it ignores biological elimination entirely — so the dose a patient actually receives is generally lower than such an estimate would suggest.
This is a genuine, practical consideration in choosing an appropriate radionuclide and tracer compound for a given procedure: a tracer with a very long biological half-life (eliminated slowly by the body) will have an effective half-life close to its physical half-life, and will continue delivering dose for close to the full physical decay time; a tracer eliminated quickly by the body will have a much shorter effective half-life, delivering a correspondingly smaller total dose, even if its physical half-life alone is long.
Key takeaways
- Physical half-life $T_P$ is the ordinary radioactive half-life of the isotope, independent of the body it is in.
- Biological half-life $T_B$ is how long the body's own metabolism and excretion take to eliminate half of an introduced substance, independent of whether it is radioactive.
- Effective half-life $T_E$ combines both loss mechanisms: $\dfrac{1}{T_E} = \dfrac{1}{T_B} + \dfrac{1}{T_P}$.
- The same relationship can be rearranged to find $T_P$ or $T_B$ given the other two quantities.
- $T_E$ is always shorter than both $T_P$ and $T_B$ individually, a direct consequence of the reciprocal-sum formula.
- Patient dose depends on $T_E$, not $T_P$ alone, since biological elimination genuinely reduces how long radioactive material remains present in the body.
- Because $T_E \lt T_P$, dose estimates based on physical half-life alone tend to overstate the true dose received.
- Choosing a tracer with an appropriate effective half-life for a given procedure is a real, clinically important part of minimising patient dose.